Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -0.05% | 191.46 | 1.2% | $560.96m | |
| GILD | Gilead Sciences, Inc. | 0.25% | 71.10 | 0.9% | $497.01m | |
| BIIB | Biogen Inc. | -1.02% | 315.82 | 1.3% | $443.97m | |
| CELG | Celgene Corporation | -0.50% | 69.89 | 1.2% | $416.33m | |
| ILMN | Illumina, Inc. | -0.38% | 310.00 | 3.5% | $396.78m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.23% | 337.89 | 2.6% | $278.31m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -3.01% | 165.19 | 1.9% | $263.19m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -1.37% | 116.90 | 2.0% | $196.35m | |
| A | Agilent Technologies, Inc. | -0.67% | 63.91 | 1.5% | $167.02m | |
| EXAS | Exact Sciences Corporation | -1.46% | 68.40 | 25.3% | $147.48m | |
| LGND | Ligand Pharmaceuticals Incorporated | 0.36% | 148.97 | 23.3% | $144.13m | |
| SRPT | Sarepta Therapeutics, Inc. | -3.86% | 112.26 | 16.4% | $128.42m | |
| ECYT | Endocyte, Inc. | -0.11% | 23.56 | 2.0% | $120.16m | |
| INCY | Incyte Corporation | 0.63% | 64.13 | 2.5% | $113.10m | |
| NKTR | Nektar Therapeutics | 2.41% | 38.25 | 5.6% | $108.41m |
Company Profile
Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop innovative, targeted medicines for cancer and other proliferative diseases. The company builds a diversified biopharmaceutical business, which is focused in hematology and oncology based on a pipeline of novel drug candidates. Its products includes CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ.